However it is limited by the fact that only in three cancers, AML, astrocytomas and oligodendroglioma we were able to perform a comparison with biologically relevant wild-type tumors and only in AML we compared the IDH1/2 mutated tumors with the normal tissue. This evidence concerns the gene IDH1 and oligodendroglioma.